...
【24h】

Sensorineural hearing loss in patients with cystic fibrosis.

机译:囊性纤维化患者的感觉神经性听力损失。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To determine the prevalence of sensorineural hearing loss (SNHL) in cystic fibrosis (CF) patients and its relationship to antibiotic use. STUDY DESIGN: Case series with chart review. SETTING: Tertiary care pediatric hospital. SUBJECTS AND METHODS: We reviewed the medical records of CF patients seen in our children's hospital between March 1994 and December 2007. Data collected included patient demographics, audiograms, tympanograms, genotype, and use of potentially ototoxic antibiotics. RESULTS: Seven of 50 (14%) patients had SNHL. Three percent of patients who received 10 courses (P<0.01). No patients who received five or fewer courses of nasal irrigation with aminoglycosides had SNHL versus 23 percent of those who received more than five courses (P<0.05). Nine percent of patients who received five or fewer courses of macrolides had SNHL versus 60 percent of those who received more than five courses (P=0.079). CONCLUSION: CF patients receiving aminoglycosides are at high risk for developing SNHL.
机译:目的:确定囊性纤维化(CF)患者的感觉神经性听力损失(SNHL)患病率及其与抗生素使用的关系。研究设计:带有图表审查的案例系列。单位:三级儿科医院。研究对象和方法:我们回顾了1994年3月至2007年12月在我们儿童医院就诊的CF患者的病历。收集的数据包括患者的人口统计学,听力图,鼓室图,基因型和潜在的耳毒性抗生素的使用。结果:50名患者中有7名(14%)患有SNHL。接受<或= 10个疗程的静脉氨基糖苷类药物的患者中有3%患有SNHL,而接受了> 10个疗程的患者中有43%的患者具有SNHL(P <0.01)。没有接受过5次或更少疗程的氨基糖苷类鼻腔冲洗的患者没有SNHL,而接受超过5次疗程的患者中有23%的患者为SNHL(P <0.05)。接受五次或更少疗程大环内酯类药物治疗的患者中有9%患有SNHL,而接受五次以上大环内酯类药物治疗的患者中有60%(P = 0.079)。结论:接受氨基糖苷类药物治疗的CF患者发生SNHL的风险较高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号